Use of hepcidin as a regulator of iron homeostasis
US7169758B2 · kind B2 · utility
7Cited by
0References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 24, 2002 |
| Grant date | Jan 30, 2007 |
| Priority date | — |
| Expiry date | May 24, 2022 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/90
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention concerns the use of hepcidin for the diagnosis and therapy of disorders of iron homeostasis. Hepcidin can be used in the treatment of disorders resulting from iron overload, while inhibitors of hepcidin can he used in the treatment of anaemia.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.